Improving survival rates for adolescents and young adults with cancer.
Carcinomas of the uterine cervix are the most common cancer of the female genital tract among females ages 15-29. In 2006, it was noted that the 5-year overall survival rates for cervical cancer had not improved over the previous 25 years for this age group. Cervical cancer occurs more often in females infected with certain types of human papilloma virus (HPV). Cervical cancer is one of the few cancers that can be identified early in the 15-29 year range through proper screening methods such as pap smears. Improved screening programs and the development of the HPV vaccine may prevent the development of invasive cervical cancers in the future.
Source: Bleyer A, O’Leary M, Barr R, Ries LAG (eds): Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, Including SEER Incidence and Survival: 1975-2000. National Cancer Institute, NIH Pub. No. 06-5767. Bethesda, MD 2006. http://seer.cancer.gov/publications/aya/
Determinants of preventive health behavior in relation to cervical cancer screening among the female population of Belgrade.
Health Educ Res. 2011 Apr;26(2):201-11
Authors: Matejic B, Vukovic D, Pekmezovic T, Kesic V, Markovic M
Identifying the factors that deter or stimulate the women to participate in screening activities is very important in order to design effective education and motivation strategies, particularly in the countries without an organized system. The study employed a case-control...
Mother-daughter communication about HPV vaccine.
J Adolesc Health. 2011 Mar;48(3):314-7
Authors: McRee AL, Reiter PL, Gottlieb SL, Brewer NT
Parent-child conversations about human papillomavirus (HPV) vaccine may provide parents with the opportunity to talk with their daughters about sexual health. We sought to characterize mothers' communication with their adolescent daughters about HPV vaccine.
PMID: 21338906 [PubMed - indexed for MEDLINE]
Stage IIIB carcinoma of the cervix in a 19-year-old: a case report.
J Reprod Med. 2011 May-Jun;56(5-6):261-4
Authors: South J, De Los Santos H, Hernandez L, Patrick S
As of December 2009, the American College of Obstetricians and Gynecologists recommends that cervical cancer screening not be initiated until age 21. However, cases, although rare, do exist of advanced cervical cancer diagnosed in women younger than age 21. Our case describes one such rare event and questions whether women should be...
Prevalence of high-risk human papillomavirus infection and cytologic results in Thailand.
Asian Pac J Cancer Prev. 2010;11(6):1465-8
Authors: Swangvaree SS, Kongkaew P, Rugsuj P, Saruk O
Cervical cancer is the second most common female cancer with a high mortality rate. The established cause is high-risk types of human papillomavirus (HPV) and a new modality for cervical cancer screening is the combination of cervical cytology with HPV testing. The aim of present study was to identify the...
Cancer incidence and mortality in Mongolia - National Registry Data.
Asian Pac J Cancer Prev. 2010;11(6):1509-14
Authors: Sandagdorj T, Sanjaajamts E, Tudev U, Oyunchimeg D, Ochir C, Roder D
The National Cancer Registry of Mongolia began as a hospital-based registry in the early 1960s but then evolved to have a population-wide role. The Registry provides the only cancer data available from Mongolia for international comparison. The descriptive data presented in this report are the first to be...
Perceptions and opinions regarding human papilloma virus vaccination among young women in Malaysia.
Asian Pac J Cancer Prev. 2010;11(6):1515-21
Authors: Al-Naggar RA, Al-Jashamy K, Chen R
The objective of this study is to explore the perceptions and opinions of young women about human papilloma virus (HPV) vaccination and associated barriers.
PMID: 21338190 [PubMed - indexed for MEDLINE]
High prevalence of human papillomavirus DNA detected in cervical swabs from women in southern Selangor, Malaysia.
Asian Pac J Cancer Prev. 2010;11(6):1645-51
Authors: Chong PP, Asyikin N, Rusinahayati M, Halimatun S, Rozita R, Ng CK, Hamilton WH, Tan BC, Noraihan N, Rohani A, Faezah H, Latiffah L, Maha A, Sabariah AR
Persistent high-risk human papillomavirus (HPV) infection is known to play an important role in the genesis of cervical cancer. Since new screening and prevention strategies, namely...
HPV vaccine awareness and willingness of first-year students entering university in Western Turkey.
Asian Pac J Cancer Prev. 2010;11(6):1695-701
Authors: Durusoy R, Yamazhan M, Taşbakan MI, Ergin I, Aysin M, Pullukçu H, Yamazhan T
The objectives of this study were to assess the level of knowledge on HPV and HPV vaccination, and to determine vaccination attitude among Ege university students in Izmir, Turkey. A cross-sectional survey was conducted in first-year English preparatory class. Systematic...
Squamous cell carcinoma antigen and cancer antigen 125 in southern Indian cervical cancer patients.
Asian Pac J Cancer Prev. 2010;11(6):1745-7
Authors: Porika M, Vemunoori AK, Tippani R, Mohammad A, Bollam SR, Abbagani S
Our objective was to evaluate the diagnostic value of squamous cell carcinoma antigen (SCC-ag) and cancer antigen (CA) 125 serum tumor markers for the detection of cervical cancer. Abnormal SCC-ag(>1.5 ng/mL) and CA125 (>35 U/mL) levels were found in 64.2% and 18.9% of a...
Comparison of Pap smear quality with anatomical spatula and convenience (spatula-cytobrush) methods: a single blind clinical trial.
Asian Pac J Cancer Prev. 2010;11(6):1769-72
Authors: Abdali K, Soleimani M, Khajehei M, Tabatabaee HR, Komar PV, Montazer NR
The Papanicolaou smear is a standard test for cervical cancer screening; however, the most important challenge is high false negative results. Several factors contribute to this problem and one the most important is inappropriate sampling. The...
Evaluation of women knowledge and attitude regarding cervical cancer early detection.
Rom J Morphol Embryol. 2011;52(1):45-51
Authors: Bădulescu F, Prejbeanu I, Rada C, Pătraşcu A, Dragomir M, Popescu FC
At European level, Romania unfortunately comes first as far as mortality due to cervical cancer is concerned, mortality rate recording a continuous increase due to disease detection in advanced stages. In this context, we followed an assessment of women's cognitive and attitudinal fund in relation...
Genotyping of human papillomavirus in cervical intraepithelial neoplasia in a high-risk population.
J Med Virol. 2011 May;83(5):833-7
Authors: Ili CG, Brebi P, López J, García P, Leal P, Suarez E, Roa JC
Infection with the human papillomavirus (HPV) is responsible for 99.7% of cervical cancers, the second most prevalent neoplasia in women worldwide and the fifth leading cause of death by cancer in this population. In Chile, the incidence rate is 14.4 cases per 100,000 women per year and it is...
from patients, caregivers and medical professionals dealing with this disease and many other diseases
Share This Tip